← Back to Search

Behavioural Intervention

Semi-autonomous myoelectric control algorithm for Upper Arm Amputation

N/A
Waitlist Available
Research Sponsored by Point Designs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (1 hour)
Awards & highlights

Study Summary

This trial is comparing the use of a semi-autonomous control algorithm with the standard of care myoelectric system for people with prosthetic hands.

Eligible Conditions
  • Upper Arm Amputation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (1 hour)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (1 hour) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of Capacity for Myoelectric Control (ACMC)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard-of-care then Semi-autonomous myoelectric controlExperimental Treatment2 Interventions
The standard of care myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand The semi-autonomous myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand.
Group II: Semi-autonomous then Standard-of-care myoelectric controlExperimental Treatment2 Interventions
The semi-autonomous myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand. The standard of care myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Semi-autonomous myoelectric control algorithm
2022
N/A
~20
Standard-of-care myoelectric control algorithm
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Point DesignsLead Sponsor
4 Previous Clinical Trials
36 Total Patients Enrolled
University of Colorado, BoulderOTHER
119 Previous Clinical Trials
29,183 Total Patients Enrolled

Media Library

Semi-autonomous myoelectric control algorithm (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05048394 — N/A
Upper Arm Amputation Research Study Groups: Semi-autonomous then Standard-of-care myoelectric control, Standard-of-care then Semi-autonomous myoelectric control
Upper Arm Amputation Clinical Trial 2023: Semi-autonomous myoelectric control algorithm Highlights & Side Effects. Trial Name: NCT05048394 — N/A
Semi-autonomous myoelectric control algorithm (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05048394 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots in this experiment for participants?

"The most recent updates on clinicaltrials.gov suggest that this medical trial is not recruiting at present, despite first being posted in January 1st 2023. Nevertheless, there are still a total of twenty other studies actively enrolling patients for participation."

Answered by AI

Who else is applying?

What site did they apply to?
University of Colorado Boulder
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I am a healthy man and hoping to get money to help my family and help science at the same time.
PatientReceived no prior treatments
~4 spots leftby Apr 2025